Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1098708rdf:typepubmed:Citationlld:pubmed
pubmed-article:1098708lifeskim:mentionsumls-concept:C0013018lld:lifeskim
pubmed-article:1098708lifeskim:mentionsumls-concept:C0181078lld:lifeskim
pubmed-article:1098708lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:1098708lifeskim:mentionsumls-concept:C0040748lld:lifeskim
pubmed-article:1098708lifeskim:mentionsumls-concept:C0013119lld:lifeskim
pubmed-article:1098708lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:1098708lifeskim:mentionsumls-concept:C0069582lld:lifeskim
pubmed-article:1098708pubmed:issue2lld:pubmed
pubmed-article:1098708pubmed:dateCreated1975-11-22lld:pubmed
pubmed-article:1098708pubmed:abstractTextA trial of a moisture vapour permeable dressing (Opsite) on split-skin graft donor sites of 53 patients has been carried out. The main advantages were freedom from pain, early healing and lack of bulky dressings. The disadvantages were post-operative leakage of fluid from under the Opsite and fragility of the newly healed donor site for the first few days. An occlusive dressing for the first 48 hours post-operatively is suggested to help overcome the leakage problem, and care of the healed donor site, with particular emphasis on not removing Opsite that is adherent to it, is stressed.lld:pubmed
pubmed-article:1098708pubmed:languageenglld:pubmed
pubmed-article:1098708pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1098708pubmed:citationSubsetIMlld:pubmed
pubmed-article:1098708pubmed:statusMEDLINElld:pubmed
pubmed-article:1098708pubmed:monthAprlld:pubmed
pubmed-article:1098708pubmed:issn0007-1226lld:pubmed
pubmed-article:1098708pubmed:authorpubmed-author:JamesJ HJHlld:pubmed
pubmed-article:1098708pubmed:authorpubmed-author:WatsonA CAClld:pubmed
pubmed-article:1098708pubmed:issnTypePrintlld:pubmed
pubmed-article:1098708pubmed:volume28lld:pubmed
pubmed-article:1098708pubmed:ownerNLMlld:pubmed
pubmed-article:1098708pubmed:authorsCompleteYlld:pubmed
pubmed-article:1098708pubmed:pagination107-10lld:pubmed
pubmed-article:1098708pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1098708pubmed:meshHeadingpubmed-meshheading:1098708-...lld:pubmed
pubmed-article:1098708pubmed:meshHeadingpubmed-meshheading:1098708-...lld:pubmed
pubmed-article:1098708pubmed:meshHeadingpubmed-meshheading:1098708-...lld:pubmed
pubmed-article:1098708pubmed:meshHeadingpubmed-meshheading:1098708-...lld:pubmed
pubmed-article:1098708pubmed:meshHeadingpubmed-meshheading:1098708-...lld:pubmed
pubmed-article:1098708pubmed:meshHeadingpubmed-meshheading:1098708-...lld:pubmed
pubmed-article:1098708pubmed:year1975lld:pubmed
pubmed-article:1098708pubmed:articleTitleThe use of Opsite, a vapour permeable dressing, on skin graft donor sites.lld:pubmed
pubmed-article:1098708pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1098708lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1098708lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1098708lld:pubmed